Psychotropics India is a finished-dose manufacturer based in India. It appears in 77 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with EFDA (ET), NAFDAC (NG) and DAV (Vietnam). Its GMP standing is certified by NAFDAC (NG) and ANVISA (Brazil). Customs aggregates show $7.7M of exports covering 1,208 molecules to 29 destinations in 2025.
| Site | FDA FEI |
|---|---|
| HARIDWAR, India | Not on file |
| Uttarkhand, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| EFDA (ET) | 52 | None |
| NAFDAC (NG) | 19 | 2 |
| DAV (Vietnam) | 3 | None |
| TMDA (TZ) | 2 | None |
| ZAMRA (ZM) | 1 | None |
| ANVISA (Brazil) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.1M | 10 |
| 2025 | Not reported | $7.7M | 29 |
| 2024 | Not reported | $6.3M | 29 |
| 2023 | Not reported | $6.1M | 33 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Psychotropics India comes back tiered against every other supplier able to file there.
Start for free